AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca cost of sales ($M) ($M)
Consolidated Income Statement (Postgres DB + Form 6-K Q1–Q4)
Latest, FY2025
10,633
Period ended Dec 31, 2025
Change on a year earlier
+4.2%
10,207 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cost of sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,633 | +4.2% | Form 20-F (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 10,207 | +23.5% | Form 20-F (filed 2025-02-18) ↗ |
| FY2023 | Dec 31, 2023 | 8,268 | -33.3% | Form 20-F (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 12,391 | -0.4% | Form 20-F (filed 2023-02-21) ↗ |
| FY2021 | Dec 31, 2021 | 12,437 | +134.7% | Form 20-F (filed 2022-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 5,299 | +7.7% | Form 20-F (filed 2021-02-16) ↗ |
| FY2019 | Dec 31, 2019 | 4,921 | -0.3% | Form 20-F (filed 2020-03-03) ↗ |
| FY2018 | Dec 31, 2018 | 4,936 | +14.3% | Form 20-F (filed 2019-03-05) ↗ |
| FY2017 | Dec 31, 2017 | 4,318 | +4.7% | Form 20-F (filed 2018-03-06) ↗ |
| FY2016 | Dec 31, 2016 | 4,126 | -11.2% | Form 20-F (filed 2018-03-06) ↗ |
| FY2015 | Dec 31, 2015 | 4,646 | – | Form 20-F (filed 2018-03-06) ↗ |
Cite this data
StockData. (2026). AstraZeneca Cost of sales ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_cor
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.